COVID-19_YHLO

YHLO

YHLO

Language

Reproductive Health

Home page

2024/06/05

JAMA Pediatrics-Susceptibility to and transmission of COVID-19 amongst children and adolescents compared with adults a systematic review and meta-analysis

2024/06/05

Nature_communications-Analysis of SARS-CoV-2 vertical transmission during pregnancy

2024/06/05

PLOS Med- Neonatal outcome in 29 pregnant women with COVID-19 A retrospective study in Wuhan, China

2024/06/05

JAMA-Antibodies in Infants Born to Mothers With COVID-19 Pneumonia

2024/06/05

JAMA-Possible Vertical Transmission of SARS-CoV-2 Froman In fected Mother to Her Newborn

2024/06/05

NC-A fourth dose of the inactivated SARS-CoV-2 vaccine redistributes humoral immunity to the N-terminal domain

2024/06/05

JI-Antibody efficacy of inactivated vaccine boosters (CoronaVac) against Omicron variant from a 15-month follow-up study

2024/06/05

NC-Contribution of low population immunity to the severe Omicron BA.2 outbreak in Hong Kong

2024/06/05

AR-Rituximab Impairs B Cell Response But Not T Cell Response to COVID‐19 Vaccine in Autoimmune Diseases

2024/06/05

NM-Three exposures to the spike protein of SARS-CoV-2 by either infection or vaccination elicit superior neutralizing immunity to all variants of concern

< 1 2 3 4 >

YHLO

Home
Products
- CLIA
  - Analyzers
  - Reagents
- Chemistry
- TLA
- LIA
- ESR
Pubilcations
- Autoimmunity
- Reproductive Health
- Diabetes
- Liver Disease
- Infection
- COVID-19
- ESR
- Others
News
- YHLO News
- Marketing Activities
About YHLO
Contact us
- Career
- Service

Add: Building 1, YHLO Biopark, Baolong 2nd Road, Baolong Subdistrict, Longgang District, 518116 Shenzhen, P.R.China

Tel: +86 755 26601910

Email: marketing@szyhlo.com

youtube

instagram

wechat

wechat

Copyright© 2024 Shenzhen YHLO Biotech Co., Ltd.

Powered by 300.cn | SEO | Business License

8

Email

marketing@szyhlo.com

9

Tel

+86 755 26601910